Your browser doesn't support javascript.
loading
Preoperative frailty parameters as predictors for outcomes after transcatheter aortic valve implantation: a systematic review and meta-analysis.
van Mourik, M S; Velu, J F; Lanting, V R; Limpens, J; Bouma, B J; Piek, J J; Baan, J; Henriques, J P S; Vis, M M.
Afiliación
  • van Mourik MS; Department of Cardiology, Amsterdam UMC, University of Amsterdam, Amsterdam Cardiovascular Sciences, Amsterdam, The Netherlands.
  • Velu JF; Department of Cardiology, Amsterdam UMC, University of Amsterdam, Amsterdam Cardiovascular Sciences, Amsterdam, The Netherlands.
  • Lanting VR; Department of Cardiology, Amsterdam UMC, University of Amsterdam, Amsterdam Cardiovascular Sciences, Amsterdam, The Netherlands.
  • Limpens J; Medical Library, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.
  • Bouma BJ; Department of Cardiology, Amsterdam UMC, University of Amsterdam, Amsterdam Cardiovascular Sciences, Amsterdam, The Netherlands.
  • Piek JJ; Department of Cardiology, Amsterdam UMC, University of Amsterdam, Amsterdam Cardiovascular Sciences, Amsterdam, The Netherlands.
  • Baan J; Department of Cardiology, Amsterdam UMC, University of Amsterdam, Amsterdam Cardiovascular Sciences, Amsterdam, The Netherlands.
  • Henriques JPS; Department of Cardiology, Amsterdam UMC, University of Amsterdam, Amsterdam Cardiovascular Sciences, Amsterdam, The Netherlands.
  • Vis MM; Department of Cardiology, Amsterdam UMC, University of Amsterdam, Amsterdam Cardiovascular Sciences, Amsterdam, The Netherlands. m.m.vis@amc.uva.nl.
Neth Heart J ; 28(5): 280-292, 2020 May.
Article en En | MEDLINE | ID: mdl-32189208
ABSTRACT
Guidelines suggest using frailty characteristics in the work-up for a transcatheter aortic valve implantation (TAVI). There are many frailty-screening tools with different components. The prognostic value of the individual parameters in frailty is as yet unclear. The objective of this systematic review and meta-analysis was to find and pool predictors for 1­year mortality after TAVI. We followed a two-step approach. First, we searched for randomised controlled trials on TAVI to identify frailty parameters used in these studies. Second, we searched for publications on these frailty parameters. Articles were included for pooled analysis if the studied frailty parameters were dichotomised with clear cut-off values based on common standards or clinical practice and reported adjusted hazard ratios (HR) of 1­year mortality after TAVI. We calculated pooled effect estimates of 49 studies based on dichotomised frailty scores (HR 2.16, 95% CI 1.57-3.00), chronic lung disease (HR 1.57, 95% CI 1.45-1.70), estimated glomerular filtration rate <30 ml/min (HR 1.95, 95% CI 1.68-2.29), body mass index <20 kg/m2 (HR 1.49, 95% CI 1.09-2.03), hypoalbuminaemia (HR 1.77, 95% CI 1.38-2.25), anaemia (HR 2.08, 95% CI 0.93-4.66), low gait speed (HR 13.33, 95% CI 1.75-101.49) and Katz activities of daily living (ADL) score of 1 or more deficits (HR 5.16, 95% CI 0.77-34.47). Chronic lung disease, chronic kidney disease, underweight, hypoalbuminaemia, a low frailty score, anaemia, low gait speed and an ADL deficiency were associated with worse 1­year outcomes after TAVI.
Palabras clave

Texto completo: 1 Banco de datos: MEDLINE Tipo de estudio: Clinical_trials / Guideline / Prognostic_studies / Risk_factors_studies / Systematic_reviews Idioma: En Año: 2020 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Tipo de estudio: Clinical_trials / Guideline / Prognostic_studies / Risk_factors_studies / Systematic_reviews Idioma: En Año: 2020 Tipo del documento: Article